<DOC>
	<DOCNO>NCT00372840</DOCNO>
	<brief_summary>RATIONALE : Printed educational material , Facing Forward Series : Life After Cancer Treatment manual , may help make transition cancer patient cancer survivor easy patient finish treatment cancer . It yet know Facing Forward Series : Life After Cancer Treatment manual The Cancer Information Service , Questions Answers fact sheet effective The Cancer Information Service , Questions Answers fact sheet alone help make life cancer treatment easy improve quality life patient breast cancer , colorectal cancer , prostate cancer , chest cancer . PURPOSE : This randomized clinical trial study well print education material work assist patient finish treatment stage I , stage II , stage IIIA breast cancer , colorectal cancer , prostate cancer , chest cancer make transition cancer patient cancer survivor easy .</brief_summary>
	<brief_title>Printed Education Materials Patients Who Are Finishing Treatment Stage I , Stage II , Stage IIIA Breast Cancer , Colorectal Cancer , Prostate Cancer , Chest Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine efficacy psychoeducational intervention comprise specific print intervention manual ( Facing Forward Series : Life After Cancer Treatment [ Facing Forward manual ] ) general print intervention fact sheet ( The Cancer Information Service , Questions Answers ) vs general print intervention fact sheet uptake recommend action ( e.g. , develop wellness plan treatment , deal pain fatigue , find support group deal feeling treatment , deal family issue treatment ) patient complete active treatment stage I-IIIA breast , prostate , colorectal , thoracic cancer . - Explore patient process evaluation Facing Forward manual term usability , comprehension , satisfaction . Secondary - Examine psychological outcome ( i.e. , depressive symptom , fear recurrence , health-related quality life , self-efficacy ) function exposure Facing Forward manual . OUTLINE : This multicenter , randomize , control , open-label , cohort study . Patients stratify accord participate center , prior chemotherapy ( yes v ) , type cancer ( breast v colorectal v prostate v thoracic ) . Patients randomize 1 2 arm . - Arm I ( intervention ) : Patients receive specific print intervention manual entitle Facing Forward Series : Life After Cancer Treatment general print intervention fact sheet entitle The Cancer Information Service , Questions Answers . - Arm II ( control ) : Patients receive general print intervention fact sheet entitle The Cancer Information Service , Questions Answers . In arm , patient evaluate baseline ( within 18 day patient 's final cancer treatment visit ) , 8 week ( via mail home material ) , 6 month ( via mail home material ) . Baseline evaluation include background information ( i.e. , demographic medical status ) , baseline use educational material , survivorship activity , psychological factor ( i.e. , depressive symptom , quality life , fear recurrence , self-efficacy ) . Psychological factor also reassess 8 week 6 month , well use educational material survivorship activity . For patient arm , uptake recommend action reassess . Patients arm I complete rating Facing Forward Series : Life After Cancer Treatment manual usability , comprehension , satisfaction 8 week 6 month . PROJECTED ACCRUAL : A total 332 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Thymoma</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast , colorectal , prostate , thoracic cancer* Stage IIII disease Approaching , attend , already attend past 28 day , last treatment appointment chemotherapy and/or radiotherapy NOTE : *Stage IIIA disease thoracic cancer exclude mesothelioma ; small cell lung cancer present must limit stage disease No 1 primary cancer No recurrent disease Hormone receptor status specify PATIENT CHARACTERISTICS : Male female Menopausal status specify Able speak/read English 8th grade level PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior brachytherapy No prior surgery ( i.e. , must receive prior adjuvant therapy surgery )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIA colon cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>limited stage small cell lung cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage IIA rectal cancer</keyword>
	<keyword>stage IIB rectal cancer</keyword>
	<keyword>stage IIC rectal cancer</keyword>
	<keyword>stage IIIA rectal cancer</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>stage I thymoma</keyword>
	<keyword>stage II thymoma</keyword>
	<keyword>stage III thymoma</keyword>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage IIA colon cancer</keyword>
	<keyword>stage IIB colon cancer</keyword>
	<keyword>stage IIC colon cancer</keyword>
	<keyword>stage IA malignant mesothelioma</keyword>
	<keyword>stage IB malignant mesothelioma</keyword>
	<keyword>stage II malignant mesothelioma</keyword>
	<keyword>stage III malignant mesothelioma</keyword>
</DOC>